Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium

In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997–2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999–2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Heirstraeten, Liesbet, Coenen, Samuel, Lammens, Christine, Hens, Niel, Goossens, Herman, Malhotra-Kumar, Surbhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2012
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437719/
https://www.ncbi.nlm.nih.gov/pubmed/22932671
http://dx.doi.org/10.3201/eid1809.120049
_version_ 1782242823531134976
author Van Heirstraeten, Liesbet
Coenen, Samuel
Lammens, Christine
Hens, Niel
Goossens, Herman
Malhotra-Kumar, Surbhi
author_facet Van Heirstraeten, Liesbet
Coenen, Samuel
Lammens, Christine
Hens, Niel
Goossens, Herman
Malhotra-Kumar, Surbhi
author_sort Van Heirstraeten, Liesbet
collection PubMed
description In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997–2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999–2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs.
format Online
Article
Text
id pubmed-3437719
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-34377192012-09-13 Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium Van Heirstraeten, Liesbet Coenen, Samuel Lammens, Christine Hens, Niel Goossens, Herman Malhotra-Kumar, Surbhi Emerg Infect Dis Dispatch In Belgium, decreasing macrolide, lincosamide, streptogramins B, and tetracycline use during 1997–2007 correlated significantly with decreasing macrolide-resistant Streptococcus pyogenes during 1999–2009. Maintaining drug use below a critical threshold corresponded with low-level macrolide-resistant S. pyogenes and an increased number of erm(A)-harboring emm77 S. pyogenes with low fitness costs. Centers for Disease Control and Prevention 2012-09 /pmc/articles/PMC3437719/ /pubmed/22932671 http://dx.doi.org/10.3201/eid1809.120049 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Van Heirstraeten, Liesbet
Coenen, Samuel
Lammens, Christine
Hens, Niel
Goossens, Herman
Malhotra-Kumar, Surbhi
Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title_full Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title_fullStr Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title_full_unstemmed Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title_short Antimicrobial Drug Use and Macrolide-Resistant Streptococcus pyogenes, Belgium
title_sort antimicrobial drug use and macrolide-resistant streptococcus pyogenes, belgium
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437719/
https://www.ncbi.nlm.nih.gov/pubmed/22932671
http://dx.doi.org/10.3201/eid1809.120049
work_keys_str_mv AT vanheirstraetenliesbet antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium
AT coenensamuel antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium
AT lammenschristine antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium
AT hensniel antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium
AT goossensherman antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium
AT malhotrakumarsurbhi antimicrobialdruguseandmacrolideresistantstreptococcuspyogenesbelgium

Ejemplares similares